Epidemiological studies are much poorer than clinical trials. I’d rather have low-N but well controlled clinical trials than nebulous epidemiological studies.
Of course, but in this pandemic we shouldn’t let the perfect be the enemy of the good. Waiting for the perfect vaccine to be developed will have a very high cost. There are no easy options here.
